Delivery Order SPE2DB24D2003-SPE2DB25FXMJ6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $134,109.38 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract calls for performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $5,094.43. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement through open competition. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vemlidy 25 mg tablets in a quantity of 30 units, with a ceiling value of $10,849.10 and a firm fixed price. This is a non-set-aside competitive award with an ultimate completion date of July 31, 2025. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $3,176.22 and a completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency awarded a $2,981.76 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Vemlidy 25 mg tablets in packages of 30 units. This is a non-set-aside, competitively awarded delivery order with firm fixed pricing and a ceiling value of $60,446.51, with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $7,213.88. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMJ6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 4, 2025, with a ceiling value of $3,991.80 and ultimate completion date of September 5, 2025. This competitive, non-set-aside contract award is classified as a firm fixed price delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to federal healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical supplier to the Defense Health Agency and military healthcare systems. The company holds a competitive standing within the federal procurement marketplace, as evidenced by its extensive portfolio of competitively awarded contracts with DLA covering a comprehensive range of pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. This award for Vemlidy, an antiviral medication, reflects the company's ongoing role in supporting Department of Defense medical supply chain requirements. The DLA Troop Support is currently planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, which may involve restructuring of future pharmaceutical procurement arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/4/25 |